Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of
Cornerstone Therapeutics Inc. Shareholders
NEW YORK -- February 25, 2013
Kirby McInerney LLP is investigating potential claims against the Board of
Directors of Cornerstone Therapeutics Inc. (“Cornerstone” or the “Company”)
(Nasdaq: CRTX) related to the proposed acquisition of the Company by Chiesi
Farmaceutici S.p.A. (“Chiesi”). Under the terms of the agreement, Chiesi will
acquire all of the outstanding common stock of Cornerstone that it does not
already own for a cash purchase price of between $6.40 and $6.70 per share.
The investigation concerns whether the Cornerstone Board of Directors is
violating its fiduciary duties and whether the proposed per share
consideration adequately values Cornerstone common shares.
If you are a Cornerstone shareholder and wish to obtain additional
information, please contact J.Brandon Walker, Esq. by email at
firstname.lastname@example.org, by telephone at (212) 699-1145 or (888) 529-4787, or by
filling out this contact form.
Kirby McInerney LLP is a New York-based law firm concentrating in securities,
shareholder, whistleblower, antitrust and consumer litigation. For additional
information, please go to www.kmllp.com.
Kirby McInerney LLP
J.Brandon Walker, Esq., 212-699-1145 or 888-529-4787
Press spacebar to pause and continue. Press esc to stop.